NEW MJ NEWS

Greenlane Reports Third Quarter 2024 Financial Results

Greenlane Holdings, Inc. (“Greenlane” or the “Company”) (Nasdaq:GNLN), one of the premier global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today reported its financial results for the third quarter and nine months ended September 30, 2024.

A Note on Our Revenue Reporting

Beginning with our second quarter 2023 earnings release, we implemented a major restructuring of our industrial product lines, transitioning much of this business from gross sales to a commission structure. While this change affects how we report revenue, we believe it enables us to preserve working capital and improve gross margins.

Third Quarter 2024 Results Compared to Prior Year Period

Total revenue was $4.0 million compared to $11.8 million in the prior year period.

Gross margin percentage increased 48.4% to 75%.

Total operating expenses were $3.6 million, a decrease of 64% compared to $10.0 million in the prior year period.

Operating loss improved by approximately $6.3 million to $538,000 compared to an operating loss of approximately $6.9 million in the prior year period.

Net loss was $3.8 million, which included a $3.2 million one-time non-cash charge for interest expense in connection with various merchant cash advances, compared to a net loss of $10.1 million in the prior year period.

Select Third Quarter 2024 Highlights Compared to Second Quarter 2024

Total revenue of approximately $4.0 million, an increase of 53.8%

Gross margin percentage increased to 75.0% from 38.1%

Total operating expenses decreased 20.0%

Loss from operations improved to $538,000 vs $3.5 million

Strategic Growth and Operational Initiatives

Initiated inventory revitalization, assortment expansion, and added complimentary products to better leverage Greenlane platform.

Exclusive multi-year distribution agreement with Safety Strips Tech Corp to distribute fentanyl, xylazine and drink spike detection test strips in the U.S.

Entered into a non-binding letter of intent to be a distributor in the U.S., Canada, Latin America, and the EU of the CURB Lifestyle, Inc. patented, non-heating, inhalation device capable of safely delivering a wide range of formulations, including nicotine, cannabinoids, and other wellness compounds.

Refocused sales team to be incentivized for growth & performance

Entered into an agreement with two senior lenders to extend the maturity of certain senior debt and additionally refinanced two merchant cash advance providers toreduce Greenlane’s total debt outstanding by over $600,000,extending maturities, and lowering near-term cash burn and interest expense.

Strengthened the balance sheet through the previously announced private placement .

“During the third quarter, we continued to make progress on strengthening our product strategy and roadmap, enhancing our sales team structure and compensation arrangement, and further extracting operating efficiencies across the enterprise,” said Barbara Sher, Chief Executive Officer for Greenlane. “We continue to see evidence that our efforts to reposition the business over the last six months have been proving successful. As we enter the next phase of our transformation, we are evolving our product portfolio with the addition of health, safety and wellness products that we believe can broaden our market opportunities and grow revenue.”

Sher added, “We are working to enhance our cash flow profile and remain focused on strengthening our balance sheet and the Company’s foundation to support long-term, sustainable, profitability and growth in the future.”

Balance Sheet

As of September 30, 2024, the Company had cash and cash equivalents of approximately $2.3 million.

GREENLANE HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except par value per share amounts)

September 30, 2024

December 31, 2023

(unaudited)

ASSETS

Current assets

Cash

$

2,309

$

463

Accounts receivable, net of allowance of $2,251 and $2,209 at
September 30, 2024 and December 31, 2023, respectively

2,313

1,693

Inventories, net

16,013

20,529

Vendor deposits

3,725

3,765

Other current assets (Note 8)

2,279

3,319

Total current assets

26,639

29,769

Property and equipment, net

2,015

2,476

Operating lease right-of-use assets

1,271

1,936

Other assets

3,894

3,912

Total assets

$

33,819

$

38,093

LIABILITIES

Current liabilities

Accounts payable

$

10,885

$

12,103

Accrued expenses and other current liabilities (Note 8)

2,521

3,056

Customer deposits

1,255

2,775

Notes payable, net of debt discount

8,626

7,283

Current portion of operating leases

886

866

Current portion of finance leases

7

Total current liabilities

24,173

26,090

Operating leases, less current portion

326

1,010

Other liabilities

1

Total long-term liabilities

326

1,011

Total liabilities

24,499

27,101

Commitments and contingencies (Note 7)

STOCKHOLDERS’ EQUITY

Preferred stock, $0.0001 par value, 10,000 shares authorized, none issued and outstanding

Class A common stock, $0.01 par value per share, 600,000 shares authorized, 972 shares issued and outstanding as of September 30, 2024; 600,000 shares authorized, 339 shares issued and outstanding as of December 31, 2023*

8

3

Class B common stock, $0.0001 par value per share, 30,000 shares authorized, and 0 shares issued and outstanding as of September 30, 2024 and December 31, 2023*

Common stock, value

Additional paid-in capital*

275,365

268,165

Accumulated deficit

(266,152

)

(257,289

)

Accumulated other comprehensive income

248

245

Total stockholders’ equity attributable to Greenlane Holdings, Inc.

9,469

11,124

Non-controlling interest

(149

)

(132

)

Total stockholders’ equity

9,320

10,992

Total liabilities and stockholders’ equity

$

33,819

$

38,093

GREENLANE HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(Unaudited)
(in thousands, except per share amounts)

Three months ended September 30,

Nine months ended September 30,

2024

2023

2024

2023

Net sales

$

4,038

$

11,800

$

11,616

$

55,384

Cost of sales

1,011

8,671

6,066

42,162

Gross profit

3,027

3,129

5,550

13,222

Operating expenses:

Salaries, benefits and payroll taxes

1,609

4,059

6,066

14,586

General and administrative

1,771

5,433

6,864

20,209

Depreciation and amortization

185

524

635

1,492

Total operating expenses

3,565

10,016

13,565

36,287

(Loss) from operations

(538

)

(6,887

)

(8,015

)

(23,065

)

Other income (expense), net:

Interest expense

(3,219

)

(3,415

)

(4,030

)

(5,148

)

Change in fair value of contingent consideration

1,000

Gain on extinguishment of debt

2,166

Other income (expense), net

204

(3

)

338

Total other income (expense), net

(3,219

)

(3,211

)

(867

)

(4,810

)

Loss before income taxes

(3,757

)

(10,098

)

(8,882

)

(27,875

)

Provision for (benefit from) income taxes

(6

)

Net loss

(3,757

)

(10,098

)

(8,882

)

(27,869

)

Less: Net income (loss) attributable to non-controlling interest

19

(17

)

(27

)

Net loss attributable to Greenlane Holdings, Inc.

$

(3,757

)

$

(10,117

)

$

(8,865

)

$

(27,842

)

Net loss attributable to Class A common stock per share – basic and diluted (Note 9)*

$

(2.28

)

$

(1.91

)

$

(12.20

)

$

(9.67

)

Weighted-average shares of Class A common stock outstanding – basic and diluted (Note 9)*

1,647

5,513

727

2,918

Other comprehensive income (loss):

Foreign currency translation adjustments

24

(1

)

181

Comprehensive loss

(3,757

)

(10,122

)

(8,883

)

(27,688

)

Less: Comprehensive loss attributable to non-controlling interest

(17

)

(8

)

Comprehensive loss attributable to Greenlane Holdings, Inc.

$

(3,757

)

$

(10,122

)

$

(8,866

)

$

(27,680

)

GREENLANE HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(in thousands)

For the nine months ended September 30,

2024

2023

Cash flows from operating activities:

Net loss (including amounts attributable to non-controlling interest)

$

(8,882

)

$

(27,869

)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

635

1,492

Equity-based compensation expense

(28

)

255

Change in provision for doubtful accounts

41

(154

)

Change in fair value of contingent consideration

(1,000

)

103

Amortization of debt discount and deferred financing fees

3,373

2,711

Gain on extinguishment of debt

(2,166

)

Other

(17

)

Changes in operating assets and liabilities, net of the effects of acquisitions:

Increase (decrease) in accounts receivable

(660

)

4,697

Decrease in inventories

4,516

18,005

Decrease in vendor deposits

40

2,945

Decrease in other current assets

1,058

3,968

Increase (decrease) in accounts payable

(1,221

)

(3,121

)

Increase (decrease) in accrued expenses and other liabilities

468

(250

)

Decrease in customer deposits

(1,520

)

(1,573

)

Net cash (used in) provided by operating activities

(5,346

)

1,192

Cash flows from investing activities:

Purchases of property and equipment, net

(173

)

(633

)

Proceeds from sale of equity investments

53

Net cash used in investing activities

(173

)

(580

)

Cash flows from financing activities:

Payments on Eyce and DaVinci promissory notes

(2,539

)

Purchase consideration paid for Eyce LLC and DaVinci acquisitions

(300

)

Repayments of Asset-Based Loan

(15,000

)

Modification costs of Asset-Based Loan

(751

)

Proceeds from issuance of Class A common stock, net of costs

5,640

3,852

Proceeds from exercise of stock options, net of costs

1,594

Proceeds from Secured Bridge Loan, net of costs

2,090

Repayments of notes payable

(2,100

)

Proceeds from notes payable

2,950

Proceeds from future receivables financing

225

3,000

Repayments of loan against future accounts receivable

(939

)

(851

)

Other

(4

)

(29

)

Net cash provided by (used in) financing activities

7,366

(10,528

)

Effects of exchange rate changes on cash

(1

)

183

Net decrease in cash

1,846

(9,733

)

Cash and restricted cash, as of beginning of the period

463

12,176

Cash and restricted cash, as of end of the period

$

2,309

$

2,443

About Greenlane Holdings, Inc.

Founded in 2005, Greenlane is a premier global platform for the development and distribution of premium smoking accessories, vape devices, and lifestyle products to thousands of producers, processors, specialty retailers, smoke shops, convenience stores, and retail consumers. We operate as a powerful family of brands, third-party brand accelerator, and an omnichannel distribution platform.

We proudly offer our own diverse brand portfolio and our exclusively licensed Marley Natural and K.Haring branded products. We also offer a carefully curated set of third-party products through our direct sales channels and our proprietary, owned and operated e-commerce platforms which include Vapor.com, PuffItUp.com, HigherStandards.com, Wholesale.Greenlane.com and MarleyNaturalShop.com.

For additional information, please visit: https://investor.gnln.com. For additional information, please visit: https://gnln.com/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning Greenlane and other matters. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this press release are only predictions. Greenlane has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. You should carefully consider the risks and uncertainties that affect our business, including those described in our filings with the Securities and Exchange Commission (“SEC”), including under the caption “Risk Factors” in Greenlane’s Annual Report on Form 10-K filed for the year ended December 31, 2023 and the Company’s other filings with the SEC, which can be obtained on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this communication. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements, whether as a result of any new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our public announcements and filings with the SEC.

Investor Contact:

IR@greenlane.com

or

TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com

SOURCE: Greenlane Holdings, Inc.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Jushi Holdings Inc. (JUSHF) to Report Fourth Quarter and Full Year 2021 Financial Results on

Jushi Holdings Inc. to Report Fourth Quarter and Full Year 2021 Financial…

 Medical Marijuana, Inc. (MJNA) Investment Company AXIM® Biotechnologies Files Patent for Unique Early Detection Cancer Biomarker

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files Patent for Unique Early…

Aurora Cannabis Inc. (ACB) Commends Germany’s Landmark Legalization Achievement

Aurora Cannabis Commends Germany’s Landmark Legalization Achievement Aurora Cannabis Inc. (NASDAQ: ACB)…